Mark Bagnall
Founder at Naia Rare Diseases LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David W. Deetz | M | - |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | 16 years |
Mark A. Powelson | M | - |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | 9 years |
Andres Acosta | M | - |
Phenomix Sciences LLC
Phenomix Sciences LLC Medical/Nursing ServicesHealth Services Phenomix Sciences LLC engages in the provision of healthcare solutions to enable personalized management of chronic diseases. The company was founded by Andres Acosta and Michael Camilleri in 2017 and is headquartered in St. Paul, MN. | 7 years |
Bethany Sensenig | F | 48 |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | - |
Barbara E. Roth | F | - |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | - |
Ross Higgins | M | - |
Phenomix Sciences LLC
Phenomix Sciences LLC Medical/Nursing ServicesHealth Services Phenomix Sciences LLC engages in the provision of healthcare solutions to enable personalized management of chronic diseases. The company was founded by Andres Acosta and Michael Camilleri in 2017 and is headquartered in St. Paul, MN. | 6 years |
Stephen Floe | M | - |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | - |
Matt Gersper | M | - |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | - |
Brian Caplin | M | - |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | - |
John Temperato | M | 59 |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | 4 years |
Jiang Zhang | M | - |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | - |
Franklyn Prendergast | M | 79 |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | - |
John Morrison | M | - |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | - |
Dale A. Wahlstrom | M | - |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | - |
Bruce F. Chafin | M | 67 |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | - |
Lynda A. Merrill | F | 74 |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | - |
Liv Williamsen | M | - |
Phenomix Sciences LLC
Phenomix Sciences LLC Medical/Nursing ServicesHealth Services Phenomix Sciences LLC engages in the provision of healthcare solutions to enable personalized management of chronic diseases. The company was founded by Andres Acosta and Michael Camilleri in 2017 and is headquartered in St. Paul, MN. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Patrick Keran | M | 52 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
Harold E. van Wart | M | 76 | 17 years | |
Vivian Liu | F | 62 | 2 years | |
Evan Levine | M | 59 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 6 years |
Craig W. Moore | M | 79 | 7 years | |
H. Perez | M | 74 |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | - |
James Stake | M | 71 |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | 12 years |
Louis Lange | M | 72 | 12 years | |
Edward Penhoet | M | 83 | 11 years | |
Adeoye Olukotun | M | 79 | 4 years | |
David T. Howard | M | 74 | - | |
John Randolph Larson | M | 77 | - | |
Diana M. Petty | F | 73 | - | |
Gregory P. Hanson | M | 77 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 2 years |
Jack Lief | M | 78 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
Carl Goldfischer | M | 65 | 17 years | |
James Xu | M | 53 | 3 years | |
James Gordon Stewart | M | 71 | 3 years | |
Eric Rowinsky | M | 67 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Brian Culley | M | 53 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 13 years |
Carrie E. Carlander McQueen | F | 53 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Robin C. Stracey | M | 66 | 5 years | |
Mark Pykett | M | 60 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
James Stewart | M | - | 4 years | |
Paul Quinlan | M | 61 | 5 years | |
Cellia Habita | M | - |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Brendan P. Rae | M | - | 5 years | |
Edward Chiang | M | - | 5 years | |
Michele L. Yelmene | F | 60 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 2 years |
Raf Hofstein | M | 74 |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | 2 years |
Rebecca Taub | M | 71 | 3 years | |
Jose Hechavarria | M | - |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Jun S. Yoon | M | - | 6 years | |
David Karpf | M | 69 | - | |
Richard L. Anderson | M | 84 | 2 years | |
Costantin Papastephanou | M | 70 |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | 7 years |
Bonnie Charpentier | M | 72 | 7 years | |
Steven M. Plumb | M | 64 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 4 years |
M. Ross Johnson | M | 79 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 years |
Michael Perry | M | 64 | 4 years | |
James C. Gilstrap | M | 88 | - | |
Alexander Denner | M | 54 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 3 years |
James A. Merritt | M | 72 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 2 years |
Robert A. Daniel | M | - |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Joachim P. H. Schupp | M | 71 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Keith Meister | M | 51 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 1 years |
John Leone | M | 77 |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | 1 years |
Gary Titus | M | 64 | 1 years | |
Mark E. Erwin | M | 59 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Jun Yoon | M | 46 | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 67 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Bagnall
- Personal Network